BridgeMD
New treatment option for Alcohol Use Disorder
Official title Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
ClinicalTrials.gov ID: NCT06105853
What this study is testing
- What it's testing
- The goal of this observational study is to investigate longitudinal stress response profiles and adaptive versus non-adaptive stress responses in alcohol use disorder. The main questions the projects aims to answer are: What are the neurobehavioral underpinnings of adaptive stress responses and resilience to repeated stress exposure with regards to: alcohol craving?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- are:
- age between 16 and 65 years
- meeting at least 2 criteria of an alcohol use disorder according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition)...
- fluency in German
- able to understand the study procedures and give informed consent
You likely can't join if
- are:
- current use of drugs or medications that interact with the central nervous system or the glucocorticoid system
- contraindications for magnetic resonance imaging
- medical history of bipolar disorder, psychotic disorder, schizophrenia or schizophrenic spectrum disorder, or substance use disorder other than...
- medical history of severe head injury or other severe central nervous system disorders or other severe somatic disorders (e.g. liver cirrhosis)
- pregnancy
See the full eligibility criteria
- are:
- age between 16 and 65 years
- meeting at least 2 criteria of an alcohol use disorder according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5), yet without the need for a therapeutic intervention
- fluency in German
- able to understand the study procedures and give informed consent
- willingness to use a study smartphone
- are:
- current use of drugs or medications that interact with the central nervous system or the glucocorticoid system
- contraindications for magnetic resonance imaging
- medical history of bipolar disorder, psychotic disorder, schizophrenia or schizophrenic spectrum disorder, or substance use disorder other than alcohol, nicotine, or cannabis
- medical history of severe head injury or other severe central nervous system disorders or other severe somatic disorders (e.g. liver cirrhosis)
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Mannheim, Baden-Wurttemberg, Germany
- Mannheim, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mannheim, Baden-Wurttemberg, Germany; Mannheim, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.